EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

EU can do more for patients with smart use of biosimilar medicines

28 April 2022

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022

EU pharmaceutical legislation must support a competitive off-patent industry to deliver equitable access to medicines

20 December 2021

Strong support for new measures to protect patient access to medicines in Northern Ireland

20 December 2021

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health

15 December 2021

Commission study highlights market framework conditions are main driver for medicines shortages

9 December 2021

Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries

26 November 2021

European Parliament report calls for increased use of off-patent medicines to improve patient access

24 November 2021

The EU must stop the offshoring of essential medicines manufacturing investments

23 November 2021

Newsroom

News about

By type

Twitter

Videos

Photos

EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

EU can do more for patients with smart use of biosimilar medicines

28 April 2022

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022

EU pharmaceutical legislation must support a competitive off-patent industry to deliver equitable access to medicines

20 December 2021

Strong support for new measures to protect patient access to medicines in Northern Ireland

20 December 2021

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health

15 December 2021

Commission study highlights market framework conditions are main driver for medicines shortages

9 December 2021

Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries

26 November 2021

European Parliament report calls for increased use of off-patent medicines to improve patient access

24 November 2021

The EU must stop the offshoring of essential medicines manufacturing investments

23 November 2021

Subscribe to our newsletter